Abstract
Background:
An individual's characteristics are reported to influence access, completion and outcomes of pulmonary rehabilitation and may contribute to health inequalities. Many countries have policies to promote equity among individuals’ characteristics, including the UK Equality Act 2010 which lists nine protected characteristics (age, disability, gender reassignment, marriage and civil partnership, pregnancy and maternity, race, religion or belief, sex and sexual orientation).
Objectives:
To describe the extent to which UK Equality Act 2010 protected characteristics have been collected and reported in UK studies and audits of pulmonary rehabilitation.
Methods:
A scoping review following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses for Scoping Reviews guidelines was conducted using five databases. UK studies and audits collecting data on pulmonary rehabilitation from 1 October 2010 (date of Equality Act 2010 inception) were eligible. The protected characteristics collected and how they were reported were extracted.
Results:
Out of 45 included studies and audits (41 studies and four audits), 98% (k=44) reported age. Sex was reported in 40% (k=18), and 20% (k=9) reported gender with only male and female categories. Half (50%, k=2) of audits reported gender with male, female and transgender categories. Race was reported through ethnicity in 2% (k=1) of studies and 75% (k=3) of audits. No studies or audits explicitly reported disability, but all reported measures indicating disease severity (e.g. forced expiratory volume in 1 s % predicted: 67%, k=30). No studies or audits reported marriage and civil partnership, pregnancy and maternity, religion or belief or sexual orientation.
Conclusions:
Protected characteristics are not commonly reported or are inconsistently reported in UK pulmonary rehabilitation studies and audits. Without reporting these characteristics, health inequalities in pulmonary rehabilitation will remain unclear.
Shareable abstract
Protected characteristics are not commonly reported or are inconsistently reported in UK studies and audits of pulmonary rehabilitation. Without these data, health inequalities relating to pulmonary rehabilitation will remain unclear. https://bit.ly/3TQO1Hm
Introduction
Pulmonary rehabilitation is an internationally recommended [1, 2] complex intervention for individuals living with chronic respiratory disease consisting of tailored exercise and education that has demonstrated improvements in health-related quality of life [3] and survival [4]. An individual's characteristics such as age, disability, gender, marital status, religion or belief, sex and race have been found to influence access, completion and outcomes of pulmonary rehabilitation [5–19] and outcomes of chronic respiratory disease [20–22], potentially contributing to health inequalities [2, 23–25]. Health inequalities highlight differences in health between individuals including health status and access, experiences and outcomes of healthcare [23, 26], such as in pulmonary rehabilitation [27]. Systemic factors such as income, housing and geographical location drive health inequalities [28] and often means individuals with certain characteristics will be more vulnerable to its effects. In recent years, reducing health inequalities have become a priority for health services [29, 30] and addressing them is a major challenge for healthcare providers globally [31, 32]. The avoidable cost of health inequalities is estimated to cost European Union member states up to EUR 1.3 trillion every year [33, 34].
Collecting and reporting an individual's characteristics in pulmonary rehabilitation studies and audits consistently allows for the monitoring of potential health inequalities and may provide information on differences in the access, completion and outcomes of pulmonary rehabilitation across individuals [35, 36]. This information can be used to establish whether services are equitable, fair and accessible for all [37, 38] and challenge health inequalities by adapting and improving services [38], including pulmonary rehabilitation [39]. Reporting guidelines such as Consolidated Standards of Reporting Trials, Strengthening the Reporting of Observational Studies in Epidemiology and Consolidated Criteria for Reporting Qualitative Research recommend the reporting of “important” characteristics of study participants; however, no specific characteristics are stated [40–42]. Without consistently collecting the characteristics of those attending pulmonary rehabilitation, effective intervention and service improvements to challenge health inequalities cannot be implemented and the widening health inequalities [28, 43] cannot be addressed in pulmonary rehabilitation.
Many European countries have legislation to reduce inequalities and improve equity and inclusivity [44–51] or are part of intergovernmental organisations (such as the United Nations) that publish antidiscrimination governance [52, 53] on individual characteristics such as age [44, 45, 47–49, 51], disability [44, 45, 47–49, 51], gender identity [48, 49, 51], marital status [46, 47], pregnancy [49], race [44, 46–51, 53], religion or belief [44–51, 53], sex [44, 47, 48, 50, 51, 53] and sexual orientation [44–49, 51]. One example of this legislation is the United Kingdom (UK) Equality Act 2010. This legislation describes protected characteristics of individuals that are illegal to discriminate against [47]. These are age, disability, gender reassignment, marriage and civil partnership, pregnancy and maternity, race, religion or belief, sex and sexual orientation [47].
The UK Equality Act 2010 protected characteristics were used in this scoping review to explore the health inequality related characteristics of individuals collected and reported in pulmonary rehabilitation research studies and audits. Accordingly, the aim of this scoping review was to describe the extent in which UK Equality Act 2010 protected characteristics have been collected and reported in UK research studies and audits of pulmonary rehabilitation to date. This review answers the following questions. 1) To what extent have UK Equality Act 2010 protected characteristics been collected as part of UK pulmonary rehabilitation research studies and audits? 2) How have UK Equality Act 2010 protected characteristics been reported in UK pulmonary rehabilitation research studies audits?
Methods
Protocol and registration
The review followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses scoping review guidelines [54]. The protocol was prospectively registered on Open Science Framework on 15 November 2022 [55].
Eligibility criteria
The Population, Intervention, Comparison, Outcomes, Study Design and Setting framework was used for article eligibility criteria. Any research study or audit conducted in the UK with adults (aged ≥18 years) participating in pulmonary rehabilitation were eligible for inclusion. The pulmonary rehabilitation programme could be carried out in any outpatient setting (e.g. home-based, centre-based, remotely delivered) in the UK [56]. There were no limitations in comparators or outcomes. Both published and unpublished research studies and audits were included; however, case studies and conference abstracts were excluded. Research studies were excluded if they started data collection prior to 1 October 2010 (prior to the inception of the UK Equality Act 2010).
Search strategy
MEDLINE, Cumulated Index to Nursing and Allied Health Literature, Scopus and APA PsycInfo were searched for relevant articles from 1 October 2010 to 15 November 2022. Searches were updated in January 2024. Preprint server medRxiv and Google Scholar were also searched. The search strategy covered key terms for pulmonary rehabilitation and is detailed in the supplementary material (supplement A).
Search results were exported into Rayyan [57] and duplicates removed. Two independent authors screened the title and abstract of each article before screening the full text for eligibility (H. Drover, L. Gardiner, E. Daynes, M.W. Orme). Any conflicts were resolved through discussion. The reference lists of included articles were checked for possible additional articles.
Data charting
Definitions of protected characteristics
In order to ensure objective data charting, clear definitions of each protected characteristic are required. The UK Equality Act 2010 defines each protected characteristic as follows.
Age: the protected characteristics of an individual's age or range of ages [47].
Disability: the protected characteristic of an individual with a physical or mental impairment that has a substantial and long-term (≥12 months) impact on an individual's ability to complete usual day-to-day activities. Disability also includes if an individual has been diagnosed with a progressive condition and this condition has an impairment on an individual's ability to complete usual day-to-day activities, even if this effect is not substantial [47]. This is likely to include most individuals who are eligible for pulmonary rehabilitation. For the purpose of this review, whether participants or service users had a disability or did not have a disability reported and measures of disability were examined.
Gender reassignment: the protected characteristic of an individual who is planning to undergo, is undergoing or has undergone medical or surgical processes to reassign their sex or an individual who does not wish to undergo medical or surgical processes, but intends to live permanently as a different gender to that which they were assigned at birth [47]. Terminology may include (but is not limited to) trans, transgender and transsexual [58].
Marriage and civil partnership: the protected characteristic of an individual who is married or is in a civil partnership [47].
Pregnancy and maternity: the protected characteristic of an individual who is pregnant [47]. Maternity refers to 26 weeks after giving birth [47].
Race: the protected characteristic of race includes an individual's colour, nationality (including citizenship), national origins and ethnicity [47].
Religion or belief: an individual's religion or philosophical belief, or lack of religion or belief. For a belief to be classed as a protected characteristic it should affect an individual's life choice [47].
Sex: a man or woman as defined by the sex on a legal document such as a passport, birth certificate or gender recognition certificate [47].
Sexual orientation: an individual's sexual orientation towards people of the same sex, opposite sex or either sex [47].
A data-charting form on Microsoft Excel mapped the extracted data and included data items such as year of publication/availability, evidence source (e.g. published, preprint), study design (e.g. randomised controlled trial, audit), sample size, participant's respiratory conditions and pulmonary rehabilitation delivery method (supplementary material B (research studies) and C (audits)). Whether protected characteristics were reported (yes/no) and how they were reported (e.g. categories reported, wording used) were extracted. If not all categories of a protected characteristic were reported (e.g. not all age categories for the protected characteristic of age; not both male and female for the protected characteristic of sex; not all participants’ race categories or ethnic groups for the protected characteristic of race); whether the majority or minority category/categories were reported was extracted. Where possible, for the protected characteristic of race, the UK census categories were used to report the data, although it is acknowledged that the categories do not contain all possible ethnic groups. The data-charting form was piloted using five eligible articles and amended before wider use. Data charting was conducted by two authors independently (H. Drover, M.W. Orme), with discrepancies resolved through discussion.
Reporting results
Results were reported descriptively using k (number of studies) (%). The results for research studies and audits were analysed separately and by each protected characteristic. Figures were created with the data visualisation software Flourish (https://flourish.studio/).
Results
15 126 research studies were identified after the initial database search. Following the removal of 4058 duplicates, titles and abstracts were screened for 11 068 research studies, with 88 meeting criteria for full-text screening, and 41 were included [59–99] (figure 1). Out of 14 eligible National Respiratory Audit Programme (NRAP) audit reports, four audit reports were included in the scoping review [16, 100–102] (figure 1).
FIGURE 1.
Preferred Reporting Items for Systematic Reviews and Meta-Analyses 2020 flow diagram. Reproduced from [100] with permission. CINAHL: Cumulated Index to Nursing and Allied Health Literature; UK: United Kingdom.
Characteristics of included research studies
Out of 41 included research studies, 35 (85%) included participants with COPD [59–61, 63, 64, 66–69, 71–80, 81, 82, 84, 85, 86–94, 96, 98, 99], five (12%) bronchiectasis [60, 65, 73, 83, 84], five (12%) asthma [62, 70, 72, 73, 84] and three (7%) interstitial lung disease [72, 84, 97] as a primary diagnosis. 38 (93%) research studies delivered pulmonary rehabilitation from a centre (hospital, community or another outpatient setting) [59–71, 73, 76–81, 82, 83, 84, 85, 86–99]; seven (17%) delivered home-based pulmonary rehabilitation [69, 72, 74, 80, 82, 86, 90]; and five (12%) delivered online home-based programmes [72, 74, 80, 82, 86]. The characteristics of included research studies are presented in table 1.
TABLE 1.
Characteristics of included research studies
First author year [ref.] | Year of data collection | Study design | Mode of pulmonary rehabilitation delivery | Primary respiratory condition | Sample size n |
---|---|---|---|---|---|
Aldabayan 2019 [89] | 2017–2018 | Observational study | Hospital centre-based | COPD | 92 |
Andrews 2015 [88] | 2012–2013 | Service evaluation | Hospital centre-based and community | COPD and other chronic respiratory conditions which are not specified | 363 |
Armstrong, 2021 [94] | 2018–2020 | RCT | Unspecified centre-based | COPD | 48 |
Barlow 2020 [87] | 2016–2017 | Service evaluation | Community | COPD | 322 |
Bourne 2017 [86] | 2015–2016 | RCT | Rehabilitation facility or online home-based | COPD | 90 |
Boutou 2014 [85] | 2012–2013 | Database analysis | Hospital centre-based | COPD | 787 |
Bradley 2022 [98] | 2020 | Qualitative interviews | Community | COPD | 9 |
Briggs-Price 2022 [84] | 2016–2019 | Propensity-matched cohort study | Hospital centre-based | COPD, bronchiectasis, asthma, ILD, other restrictive, other | 1492 |
Chalmers 2019 [83] | 2014–2018 | Pilot RCT | Hospital centre-based | Bronchiectasis | 48 |
Chaplin 2022 [82] | 2013–2015 | Exploratory feasibility study | Hospital centre-based, community or online home-based | COPD | 103 |
Chaplin 2015 [81] | 2011–2012 | Retrospective audit | Hospital centre-based | COPD | 200 |
Chaplin 2017 [80] | 2013–2015 | Randomised controlled feasibility study | Hospital centre-based, community or online home-based | COPD | 103 |
Cox 2018 [90] | 2015–2016 | Parallel-group, pilot 2×2 factorial randomised trial with nested qualitative research and an economic analysis | Hospital centre-based and home-based | COPD | 61 |
Edwards 2023 [95] | 2012–2017 | Cohort study | Hospital centre-based | IPF | 166 |
Finnegan 2023 [96] | 2013–2020 | Experimental medicine study | Hospital centre-based or community | COPD | 72 |
France 2021 [79] | 2018–2019 | Prospective observational study | Hospital centre-based | COPD | 112 |
Jenkins 2020 [77] | 2016–2018 | Prospective cohort study | Community | COPD | 85 |
Jenkins 2020 [78] | 2016–2018 | Prospective cohort study | Community | COPD | 40 |
Jones 2015 [76] | 2011–2014 | Case–control | Hospital centre-based | COPD | 622 |
Jones 2014 [75] | 2011–2012 | Audit | Unspecified | COPD | 448 |
Jung 2020 [74] | 2018 | Mixed methods | Online home-based | COPD | 10 |
Knox 2019 [73] | 2017–2018 | Service evaluation | Hospital centre-based or community | COPD, bronchiectasis, pulmonary fibrosis, chronic asthma, other | 45 |
Lewis 2021 [72] | 2019–2020 | Mixed methods | Online home-based | COPD, ILD, asthma | 30 |
Maddocks 2016 [71] | 2011–2015 | Prospective cohort study | Hospital centre-based | COPD | 816 |
Majd 2020 [70] | 2014–2017 | Feasibility study of RCT | Hospital centre-based | Severe asthma | 61 |
McDonnell 2014 [93] | 2011–2012 | Prospective controlled “before and after” study | Hospital centre-based or community | COPD | 52 |
Nikoletou 2023 [97] | 2014–2015 | Randomised controlled pilot feasibility trial | Hospital centre-based | ILD | 58 |
Nolan 2019 [69] | 2012–2015 | Propensity-matched cohort study | Community or home-based | COPD | 154 |
Nolan 2017 [68] | 2012–2014 | RCT | Hospital centre-based | COPD | 152 |
Nolan 2022 [67] | 2013–2018 | Propensity matched real-world study | Hospital centre-based | COPD, IPF | 326 |
O’Neill 2018 [66] | 2014–015 | Mixed methods | Hospital centre-based | COPD | 49 |
Patel 2023 [99] | 2018–2019 | Cohort study | Unspecified centre-based | COPD | 24 |
Patel 2021 [64] | 2011–2016 | Propensity-matched analysis | Hospital centre-based or community | COPD | 636 |
Patel 2019 [65] | 2012–2016 | Propensity-matched control study | Hospital centre-based or community | Bronchiectasis | 426 |
Pavitt 2020 [63] | 2015–2018 | Randomised parallel-group study | Hospital centre-based | COPD | 165 |
Ricketts 2022 [62] | 2017–2020 | Pragmatic RCT | Hospital centre-based | Difficult-to-control asthma | 95 |
Ward 2021 [61] | 2016–2018 | Single-arm feasibility trial | Hospital centre-based | COPD | 19 |
Wynne 2020 [60] | 2012–2017 | Matched observational cohort study | Hospital centre-based | COPD, bronchiectasis | 124 |
Yohannes 2021 [59] | 2014–2016 | Prospective trial | Community | COPD | 165 |
Yohannes 2022 [91] | 2013–2019 | Cohort study | Community | COPD | 734 |
Yohannes 2022 [92] | 2013–2019 | Database analysis | Community | COPD | 993 |
RCT: randomised controlled trial; ILD: interstitial lung disease; IPF: idiopathic pulmonary fibrosis.
Protected characteristics in pulmonary rehabilitation research studies
Figure 2 summarises the protected characteristics reported in the research studies. Further reporting details are detailed in the supplementary material (supplement D).
FIGURE 2.
Summary of the protected characteristics reported in the included research studies.
Age
Age was the most frequently reported protected characteristic (98%, k=40) [59–74, 76–99]. Age was most commonly reported as mean±sd (80%, k=33) [59–61, 64–74, 76–78, 80–82, 84–95, 97], followed by median (interquartile range (IQR)) (12%, k=5) [62, 63, 79, 83, 99]. Each of the individual participants’ ages was reported in one (2%) of the research studies [74].
Sex
The sex of participants was reported in 44% (k=18) of research studies [59, 61, 62, 64, 65, 67, 68, 70, 71, 79, 81, 83, 85, 89, 90, 96, 98, 99]. Gender was reported in 20% (k=8) of research studies with only two categories (male/female) [66, 72, 74, 82, 87, 88, 91, 94]. In 17% (k=7) of research studies it was unclear if authors reported sex or gender [73, 76–78, 84, 92, 94]; 7% (k=3) used the terms “sex” and “gender” interchangeably [76, 84, 92]; and 10% (k=4) reported either male or female, but did not state if this was sex or gender [73, 77, 78, 95].
In research studies where only one gender or sex category was reported, 64% (k=16) reported the majority [59–61, 67, 68, 70, 71, 77–80, 83, 84, 86, 95, 97]. When a sample was predominantly male, 76% (k=13) reported only the male category [59, 61, 67, 68, 71, 77–80, 84, 86, 95, 97]. When a sample was predominantly female, the female category was reported in 38% (k=3) of research studies [60, 70, 83].
Race
No research studies explicitly used the term “race”. Ethnicity was reported in one (2%) study [88]. Ethnicity was reported as n (%) for White British, Irish, White other, Mixed British and African ethnic groups [88]. Three (7%) research studies did not report the ethnicity or race of participants, but discussed participants being predominantly or all “Caucasian” as a study limitation [59, 91, 92].
Disability
No research studies explicitly reported that their participants had a disability. 98% of research studies reported measures of disability, including disease severity, exercise capacity or breathlessness [59–97, 99]. Forced expiratory volume in 1 s (FEV1) % predicted was the most common marker of disease severity (73%, k=30) [59–71, 76, 77, 79, 80, 82–86, 89–94, 96, 99], incremental shuttle walk test for exercise capacity (66%, k=27) [59–61, 63–71, 73, 76, 77, 80–82, 84, 85, 87, 89, 91–93, 95, 99] and Medical Research Council (MRC) dyspnoea scale for breathlessness (59%, k=24) [60–64, 66–74, 76, 79–82, 84, 85, 95, 96, 99].
Gender reassignment, pregnancy and maternity, marriage and civil partnership, religion or belief and sexual orientation
No research studies reported gender reassignment, marriage and civil partnership, pregnancy and maternity, religion or belief or sexual orientation.
Characteristics of included pulmonary rehabilitation audits
Table 2 presents the characteristics of the included audits. All audits were published by the NRAP, formerly known as the National Asthma and COPD Audit Programme. NRAP reports the data for individuals with COPD who have been referred to pulmonary rehabilitation and that have consented for their data to be entered into NRAP pulmonary rehabilitation audits. Of the four included audits, three (75%) were clinical audits [101–103] and one (25%) was a joint clinical and organisational audit [16]. All audits (k=4) included both centre-based and home-based pulmonary rehabilitation programmes [16, 101–103].
TABLE 2.
Characteristics of included audits
First author year [ref.] | Year of data collection | Audit type | Mode of pulmonary rehabilitation delivery | Primary respiratory condition | Number of service users |
---|---|---|---|---|---|
Steiner 2016 [103] | 2015 | Clinical | Hospital centre-based, community and home-based | COPD | 7413 |
Singh 2020 [ 102 ] | 2019 | Clinical | Hospital centre-based, community and home-based | COPD | 6056 |
Singh 2020 [101] | 2019 | Clinical | Hospital centre-based, community and home-based | COPD | 12 127 |
Singh 2020 [16] | 2019 | Clinical and organisational | Hospital centre-based, community and home-based | COPD | 12 127 |
Protected characteristics in pulmonary rehabilitation audit reports
Figure 3 summarises the protected characteristics reported by the included pulmonary rehabilitation audits. Further reporting details are detailed in the supplementary material (supplement E).
FIGURE 3.
Summary of the protected characteristics reported in the included audits.
Age
Of the four included audits, 100% reported age (k=4). All audits reported age as median (IQR) (71 (64–76) years [16, 101], 70 (64–76) years [102, 103]), with one audit additionally reporting age as mean±sd (69±9 years) and using frequency data of age categories (<65 years (30%), 65–74 years (42%), 75–84 years (25%) and ≥85 years (4%)) [103].
Sex
No audits explicitly reported sex. One (25%) audit reported male and female categories without explicitly stating if these were sex or gender [103] and one (25%) audit reported gender with male and female categories [16].
Gender reassignment
Two (50%) audits reported gender with male, female, transgender, other and not recorded/prefers not to say categories [101, 102].
Disability
No audits explicitly reported that their service users had a disability or did not have a disability as defined by the UK Equality Act 2010 associated with their COPD. Breathlessness, disease severity, and comorbidities, which may be considered measures of disability, were reported by all audits [16, 101–103]. These included MRC dyspnoea scale (k=4, 100%) as a marker of breathlessness [16, 101–103], FEV1 (k=4, 100%) [16, 101–103] and FEV1/forced vital capacity (k=3, 75%) [16, 101, 102] as markers of disease severity, and cardiovascular disease (k=4, 100%) [16, 101–103], history of lower limb or lower back musculoskeletal disorders (k=3, 75%) [16, 101, 102] and mental illness (k=3, 75%) [16, 101, 102] as comorbidities.
Race
No audits used the term “race”. The ethnicity of service users attending pulmonary rehabilitation was reported in 75% (k=3) of audits [16, 101, 103]. In two (50%) audits, only the White British ethnic group was reported, with this ethnic group being the majority of the service users (94% [103] and 82.5% [16]). One audit reported 16 ethnicity categories (in addition to “not stated”), with the most common categories being White British (82.5%), not stated (11.4%), White Irish (1.5%) and any other White background (1.3%) [101].
Marriage and civil partnership, pregnancy and maternity, religion or belief and sexual orientation
No audits reported the characteristics of marriage and civil partnership, pregnancy and maternity, religion or belief and sexual orientation.
Discussion
This scoping review has identified that protected characteristics are not commonly reported or are inconsistently reported in UK pulmonary rehabilitation research studies and audits. Of the 45 included research studies and audits, age was well collected and reported. Sex was inconsistently reported in research studies. No audits reported sex and usually reported the gender of service users, with half of audits using categories that allowed the expression of gender reassignment. No research studies or audits explicitly reported disability, marriage and civil partnership, pregnancy and maternity, religion or belief or sexual orientation. Without consistently reporting protected characteristics, health inequalities relating to an individual's characteristics in pulmonary rehabilitation will remain unclear.
In order to understand any health inequalities that may exist, appropriate data must be collected [104–106]. In this review of UK research studies and audits, overall audits reported more data on service users’ characteristics than research studies, which may be due to audits reporting on population-level data. However, the audits do not report how much data is missing, so it is unclear how well service users’ characteristics are collected across the UK by pulmonary rehabilitation services inputting data into the audit. No research studies or audits explicitly reported data on disability, marriage and civil partnership, pregnancy and maternity, religion or belief or sexual orientation. By not consistently reporting protected characteristics in pulmonary rehabilitation research studies and audits, the characteristics of individuals accessing and not accessing pulmonary rehabilitation are unclear. As a result, the representativeness, equity and inclusivity of pulmonary rehabilitation across individual characteristics, and therefore health inequalities, are unknown. Furthermore, more evidence is needed to determine whether the intervention is equally effective across all characteristics [107, 108]. To address this, the collection of data is vital [38]. Any results from collecting the data can be used to promote health equity by proposing where evidence-based changes are required in practices, policies and programmes [109], for example in adapting pulmonary rehabilitation to improve uptake and adherence in those least likely to attend [39]. As data on these characteristics have not been commonly collected, then any health inequalities among these characteristics cannot be identified or monitored and improvements cannot be made [104, 109–111]. The significant economic costs of health inequalities cannot be reduced without investing in programmes that target systematically identified health inequalities [33]. Social determinants of health (sex, race/ethnicity, income, education, occupation and social class) [112] are also underreported in advanced chronic respiratory interventions (including pulmonary rehabilitation), meaning that inequalities related to these characteristics that may limit access or completion of respiratory interventions cannot be addressed [111]. Additionally, by capturing data on participants’ gender identity (including if an individual identifies as having the protected characteristic of gender reassignment) and sexual orientation, it empowers individuals (if they wish to disclose this information) with these lived experiences and promotes equality and inclusion [110, 113].
Inconsistency in the reporting of protected characteristics was evident in some pulmonary rehabilitation research studies and audits, particularly when reporting sex. The terms “sex” and “gender” were used interchangeably in several research studies and gender was reported with only male and female categories in approximately a quarter of research studies and audits. No studies or audits explicitly reported nonbinary gender identities or intersex individuals, who account for 0.06% of the UK population [114] and 1.7% of the global population [115], respectively. It is possible that the data reported in male and female genders included other gender identities, and that male and female sex categories included intersex individuals. Sex and gender are different concepts [116–118] and there are more than two gender identities [113, 118]. Sex and gender are commonly used interchangeably and incorrectly in society [118–120] and in health research [121]. However, it is important to understand the difference as there are sex-specific and gender-specific determinants of health [117, 120]. In all research studies and audits that reported race, the term “ethnicity” was used. An individual self-identifies their ethnicity using factors such as culture, language, religion and nationality [122, 123]. In contrast, race is determined by physical characteristics and is a social construct used to group people [123]. Ethnicity is the term used by the UK Census [124], which may explain why ethnicity was reported instead of race in the UK. In other parts of the world, “ethnic identity” (Australia, Bulgaria, Canada, Czech Republic, Hungary, Ireland, Israel, Latvia, Lithuania, New Zealand, Romania, Russia, Slovakia, Slovenia, UK, the United States) and “indigenous identity” (Australia, Canada, Chile, Colombia, Costa Rica, Mexico, New Zealand, the United States) are used to report ethnicity [125].
Where ethnicity was reported, the categories used to report ethnicity varied. In half of audits only the White British ethnic group was reported, but when more than one ethnic group was reported, the number of ethnic groups reported varied considerably. The vast majority of service users in the research studies and audits identified as White British. Ethnic minority groups being underrepresented in research is not exclusive to pulmonary rehabilitation research. Underrepresentation of ethnic minority groups has also been reported in cardiovascular disease [107, 126], diabetes [127] and coronavirus disease 2019 (COVID-19) [128, 129] research. However, if an intervention has been assessed in participants who are predominantly White British, it cannot be assumed that it will be equally effective across all other ethnicities [107, 108]. Furthermore, reduced representation of ethnic minority groups in trials has been found to have wider implications, such as reduced trust and uptake of COVID-19 vaccines in ethnic minority groups [130], which may apply to other interventions or services, such as pulmonary rehabilitation. In a recent scoping review assessing the reporting of race/ethnicity as a social determinant of health in advanced chronic respiratory interventions, ethnicity was also found to be reported in a very small number of studies, limiting the understanding of factors that may be influencing health inequalities [111].
To improve the collection of individual characteristics, such as the nine protected characteristics, reporting frameworks for research studies and audits would be beneficial. Only characteristics that an individual was comfortable to disclose should be collected; however, studies have shown that the majority of service users are willing to provide their characteristics in healthcare settings [131–133]. The method of collecting these data should also be considered (e.g. a clinician or researcher asking for the information or an individual completing a form with this information) to ensure that an individual feels comfortable. Data governance should ensure individual anonymity in data reports where characteristics are rare. Reporting frameworks and guidelines have been proposed for sex and gender [134, 135] and ethnicity [136, 137], but no framework or guidelines have been widely adopted in pulmonary rehabilitation. The International Committee of Medical Journal Editors has stated that researchers should strive for participants who are representative and inclusive in age, sex and ethnicity across all study types and provide descriptive data of these characteristics as a minimum [138]. Local frameworks would be required to ensure the population demographics collected meet legislation and the needs of the population. For example, it is illegal to collect religion and ethnicity data in France [139] and the collection of ethnicity data is highly limited in Austria, Belgium, Germany, Luxembourg, Portugal, Slovenia, Sweden and Turkey [125], so a reporting framework for pulmonary rehabilitation in these countries would need to reflect this. Local frameworks could also include additional categories to be collected if relevant to the region or country, in order to meet the needs of the population eligible for pulmonary rehabilitation. This would improve the transparency of participants characteristics in pulmonary rehabilitation and allow the accessibility, representativeness, inclusivity and effectiveness of pulmonary rehabilitation to be assessed appropriately to the local area. This could improve pulmonary rehabilitation delivery by providing information to guide service improvements that can advance equality of opportunity in accessing health services [37] and potentially reduce health inequalities. Further research on any barriers to healthcare professionals and researchers collecting an individuals’ characteristics would be beneficial.
In order to assess the characteristics of who is attending pulmonary rehabilitation, we suggest that all protected characteristics should be collected and made available upon request. However, as a minimum, to report and monitor health inequalities, we would recommend local frameworks report based on the following guidance.
Age: this should be reported as an average with distribution, where possible.
Sex and/or gender: clarity reporting sex and/or gender is essential and terms should be used consistently. If reporting a single sex, the majority sex should be reported. Pay consideration to all gender identity categories, and be clear in reporting if the categories reported represent the entire sample or if smaller categories have been omitted from reporting.
Disability: an individual's perception of their disability should be reported (e.g. does their respiratory condition have an impairment on their ability to complete usual day-to-day activities?) and may be collected through measures of the functional ability (e.g. MRC score).
Ethnicity: if legislation allows, the ethnicity of individuals should be reported. All ethnic groups, using language and categories that are appropriate to the region or country, should be reported, rather than a single ethnic group. If ethnic groups have been clustered, justifications for this should be provided. In ethnic groups where the number of individuals is small enough that it may identify individuals, the numbers or percentages should not be reported, but this should be explained by the authors.
Other characteristics that are important for the local population: other characteristics that are important to the region or country's health inequalities (socioeconomic status, urban/rural, etc.) should be collected. This should be reported in line with national guidance where the research was conducted.
This scoping review assessed individual's characteristics collected and reported in pulmonary rehabilitation research studies and audits using the UK's protected characteristics as an example. Ensuring that pulmonary rehabilitation study participants and service users reflect the diversity of the population eligible for pulmonary rehabilitation and the principle of not discriminating against individuals based on their characteristics is applicable globally. However, other countries may have different policies compared to the UK, and with different health inequalities unrelated to protected characteristics, which need to be accounted for. Furthermore, although protected characteristics are not commonly reported in UK pulmonary rehabilitation studies and audits, this may not reflect a lack of diversity, but a lack of data collected. Future work should include the development of local frameworks for collecting and reporting individual's characteristics and exploring the equity of access, completion and outcomes across such groups in order to investigate health inequalities in pulmonary rehabilitation.
In conclusion, protected characteristics are either not commonly reported or are inconsistently reported in UK pulmonary rehabilitation research studies and audits. Local reporting frameworks for individual's characteristics in pulmonary rehabilitation may support in identifying the health inequalities to be addressed in pulmonary rehabilitation research and services.
Points for clinical practice
By collecting and reporting protected characteristics in pulmonary rehabilitation research studies and audits, services may be able to better adapt to meet the needs of those who are not currently accessing services, which may reduce health inequalities.
Supplementary material
Please note: supplementary material is not edited by the Editorial Office, and is uploaded as it has been supplied by the author.
Supplementary material ERR-0236-2023.SUPPLEMENT (813.4KB, pdf)
Footnotes
Provenance: Submitted article, peer reviewed.
Conflict of interest: All authors declare no competing interests.
Support statement: This work was funded in whole by the Wellcome Trust (204801/Z/16/Z) and as part of the Leicestershire Health Inequalities Improvement Doctoral Training Programme (223512/Z/21/Z). This is independent research funded by the Wellcome Trust and carried out at the National Institute for Health and Care Research (NIHR) Leicester Biomedical Research Centre (BRC). S.J. Singh is an NIHR Senior Investigator. The views expressed are those of the authors and not necessarily those of the Wellcome Trust, the NIHR or the Department of Health and Social Care. Funding information for this article has been deposited with the Crossref Funder Registry.
References
- 1.Spruit MA, Singh SJ, Garvey C, et al. An official American Thoracic Society/European Respiratory Society statement: key concepts and advances in pulmonary rehabilitation. Am J Respir Crit Care Med 2013; 188: e13–e64. doi: 10.1164/rccm.201309-1634ST [DOI] [PubMed] [Google Scholar]
- 2.Rochester CL, Alison JA, Carlin B, et al. Pulmonary rehabilitation for adults with chronic respiratory disease: an official American Thoracic Society clinical practice guideline. Am J Respir Crit Care Med 2023; 208: e7–e26. doi: 10.1164/rccm.202306-1066ST [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.McCarthy B, McDonald CF. Review: pulmonary rehabilitation improves health-related QoL and exercise capacity more than usual care in COPD. Ann Intern Med 2015; 162: JC4. doi: 10.7326/ACPJC-2015-162-12-004 [DOI] [PubMed] [Google Scholar]
- 4.Houchen-Wolloff L, Williams JEA, Green RH, et al. Survival following pulmonary rehabilitation in patients with COPD: the effect of program completion and change in incremental shuttle walking test distance. Int J Chron Obstruct Pulmon Dis 2017; 13: 37–44. doi: 10.2147/COPD.S143101 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Bennett D, Bowen B, McCarthy P, et al. Outcomes of pulmonary rehabilitation for COPD in older patients: a comparative study. COPD 2017; 14: 170–175. doi: 10.1080/15412555.2016.1258051 [DOI] [PubMed] [Google Scholar]
- 6.Spruit MA, Augustin IML, Vanfleteren LE, et al. Differential response to pulmonary rehabilitation in COPD: multidimensional profiling. Eur Respir J 2015; 46: 1625–1635. doi: 10.1183/13993003.00350-2015 [DOI] [PubMed] [Google Scholar]
- 7.Spitzer KA, Stefan MS, Priya A, et al. A geographic analysis of racial disparities in use of pulmonary rehabilitation after hospitalization for COPD exacerbation. Chest 2020; 157: 1130–1137. doi: 10.1016/j.chest.2019.11.044 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Berry MJ, Rejeski WJ, Adair NE, et al. Exercise rehabilitation and chronic obstructive pulmonary disease stage. Am J Respir Crit Care Med 1999; 160: 1248–1253. doi: 10.1164/ajrccm.160.4.9901014 [DOI] [PubMed] [Google Scholar]
- 9.Maestri R, Vitacca M, Paneroni M, et al. Gender and age as determinants of success of pulmonary rehabilitation in individuals with chronic obstructive pulmonary disease. Arch Bronconeumol 2023; 59: 174–177. doi: 10.1016/j.arbres.2022.09.008 [DOI] [PubMed] [Google Scholar]
- 10.Di Meo F, Pedone C, Lubich S, et al. Age does not hamper the response to pulmonary rehabilitation of COPD patients. Age Ageing 2008; 37: 530–535. doi: 10.1093/ageing/afn126 [DOI] [PubMed] [Google Scholar]
- 11.Kim H-J, Choi H-E, Jang H-J, et al. Current status and trends of pulmonary rehabilitation in South Korea: national level data analysis using Health Insurance Review and Assessment Service (HIRA) database from 2016 to 2018. Medicine 2022; 101: e31085. doi: 10.1097/MD.0000000000031085 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.McCarron EP, Bailey M, Leonard B, et al. Improving the uptake: barriers and facilitators to pulmonary rehabilitation. Clin Respir J 2019; 13: 624–629. doi: 10.1111/crj.13068 [DOI] [PubMed] [Google Scholar]
- 13.Laviolette L, Lacasse Y, Doucet M, et al. Chronic obstructive pulmonary disease in women. Clin Respir J 2007; 14: 93–98. doi: 10.1155/2007/463435 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Verrill D, Barton C, Beasley W, et al. The effects of short-term and long-term pulmonary rehabilitation on functional capacity, perceived dyspnea, and quality of life. Chest 2005; 128: 673–683. doi: 10.1378/chest.128.2.673 [DOI] [PubMed] [Google Scholar]
- 15.Betancourt-Peña J, Ávila-Valencia JC, Facundo-Duarte A. Effects of pulmonary rehabilitation in men compared to women with chronic obstructive pulmonary disease in Colombia. Aquichan 2021; 21: e2116. doi: 10.5294/aqui.2021.21.1.6 [DOI] [Google Scholar]
- 16.Singh S, Latchem S, Andrews R, et al. National Asthma and Chronic Obstructive Pulmonary Disease Audit Programme (NACAP). Pulmonary Rehabilitation Audit Report 2019. Combined Clinical and Organisational Audit of Pulmonary Rehabilitation Services in England, Scotland and Wales. London, Royal College of Physicians, 2020. [Google Scholar]
- 17.Candy S, Reeve J, Dobson R, et al. Characteristics of pulmonary rehabilitation programmes in New Zealand: a survey of practice prior to and during COVID-19. N Z Med J 2022; 135: 13–25. [PubMed] [Google Scholar]
- 18.McNaughton AA, Weatherall M, Williams G, et al. An audit of pulmonary rehabilitation program. Clinical Audit 2016; 8: 7–12. Doi: 10.2147/CA.S111924 [DOI] [Google Scholar]
- 19.Man W, Chaplin E, Daynes E, et al. British Thoracic Society Clinical Statement on pulmonary rehabilitation. Thorax 2023; 78: Suppl. 4, s2–s15. doi: 10.1136/thorax-2023-220439 [DOI] [PubMed] [Google Scholar]
- 20.Chai Y-H, Yang H, Huang G-P, et al. Nursing outcomes and risk factors of patients with chronic obstructive pulmonary disease after discharge. Int J Chron Obstruct Pulmon Dis 2021; 16: 2911–2916. doi: 10.2147/COPD.S321375 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Green MR, Emery CF, Kozora E, et al. Religious and spiritual coping and quality of life among patients with emphysema in the National Emphysema Treatment Trial. Respir Care 2011; 56: 1514–1521. doi: 10.4187/respcare.01105 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Somayaji R, Chalmers JD. Just breathe: a review of sex and gender in chronic lung disease. Eur Respir Rev 2022; 31: 210111. doi: 10.1183/16000617.0111-2021 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Williams E, Buck D, Babalola G, et al. What are Health Inequalities? The King's Fund. 2022. www.kingsfund.org.uk/publications/what-are-health-inequalities. Date last updated: 17 June 2022.
- 24.Office for Health Improvement and Disparities . Health Disparities and Health Inequalities: Applying All Our Health. 2022. www.gov.uk/government/publications/health-disparities-and-health-inequalities-applying-all-our-health/health-disparities-and-health-inequalities-applying-all-our-health#:∼:text=protected%20characteristics%20under%20the%20Equality,religion%20or%20belief%2C%20and%20disability. Date last updated: 11 October 2022.
- 25.Public Health England . Health Inequalities Briefing for London NHS Health Checks and Target Diseases: Inequalities by Protected Characteristics and Socioeconomic Factors. London, Public Health England, 2015. [Google Scholar]
- 26.Public Health England . COVID-19 Place-Based Approach to Reducing Health Inequalities. 2020. PHE Publications Gateway Number: GOV-8343.
- 27.Gardiner L, Singh S. Inequality in pulmonary rehabilitation – the challenges magnified by the COVID-19 pandemic. Chron Respir Dis 2022; 19: 14799731221104098. doi: 10.1177/14799731221104098 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Marmot M. Health equity in England: the Marmot review 10 years on. BMJ 2020; 368: m693. doi: 10.1136/bmj.m693 [DOI] [PubMed] [Google Scholar]
- 29.National Health Service (NHS) . The NHS Long Term Plan. 2019. www.longtermplan.nhs.uk.
- 30.Ministère des Solidarités et de la Santé . National Health Strategy. 2017. https://sante.gouv.fr/IMG/pdf/dossier_sns_2017_synthesev6-10p_anglaisv2.pdf. Date last accessed: 26 April 2024.
- 31.Scholz N. Addressing Health Inequalities in the European Union: Concepts, Action, State of Play. Brussels, EPRS European Parliamentary Research Service, 2020. Contract number: PE 646.182. [Google Scholar]
- 32.World Health Organization (WHO) . Urgent Health Challenges for the Next Decade. 2020. www.who.int/news-room/photo-story/photo-story-detail/urgent-health-challenges-for-the-next-decade. Date last accessed: 18 October 2023. Date last updated: 13 January 2020.
- 33.Mackenbach JP, Meerding WJ, Kunst AE. Economic costs of health inequalities in the European Union. J Epidemiol Community Health 2011; 65: 412–419. doi: 10.1136/jech.2010.112680 [DOI] [PubMed] [Google Scholar]
- 34.Equity Action . €1.3 Trillion – the Avoidable Cost of Health Inequalities Across the EU (Higher Than Every Member State's Annual GDP, Bar Germany, UK, France & Italy). Brussels, Equity Action, 2014. [Google Scholar]
- 35.Darko N. Not ‘Hard to Reach’ – Increasing Diversity in Research Participation NHS England. 2023. www.england.nhs.uk/blog/not-hard-to-reach-increasing-diversity-in-research-participation/. Date last updated: 14 February 2023.
- 36.Willis A, Isaacs T, Khunti K. Improving diversity in research and trial participation: the challenges of language. Lancet Public Health 2021; 6: e445–e446. doi: 10.1016/S2468-2667(21)00100-6 [DOI] [PubMed] [Google Scholar]
- 37.NHS England . Monitoring Equality and Health Inequalities: a Position Paper. Report No.: 1.0. 2015. www.england.nhs.uk/wp-content/uploads/2015/03/monitrg-ehi-pos-paper.pdf
- 38.Moorthie S, Peacey V, Evans S, et al. A scoping review of approaches to improving quality of data relating to health inequalities. Int J Environ Res Public Health 2022; 19: 15874. doi: 10.3390/ijerph192315874 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Watson JS, Jordan RE, Gardiner L, et al. A systematic review of the effectiveness of interventions to promote referral; adherence; and uptake of pulmonary rehabilitation for patients with chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis 2023; 18: 1637–1654. doi: 10.2147/COPD.S396317 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Tong A, Sainsbury P, Craig J. Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups. Int J Qual Health Care 2007; 19: 349–357. doi: 10.1093/intqhc/mzm042 [DOI] [PubMed] [Google Scholar]
- 41.von Elm E, Altman DG, Egger M, et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. J Clin Epidemiol 2008; 61: 344–349. doi: 10.1016/j.jclinepi.2007.11.008 [DOI] [PubMed] [Google Scholar]
- 42.Schulz KF, Altman DG, Moher D, et al. CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. BMC Med 2010; 8: 18. doi: 10.1186/1741-7015-8-18 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Marmot M. Fair Society, Healthy Lives: the Marmot Review. 2013. Available from: www.ucl.ac.uk/marmotreview [Google Scholar]
- 44.Federal Ministry of Justice . General Act on Equal Treatment of 14 August 2006. Date last accessed: 19 January 2024. Date last updated: 19 December 2022. www.gesetze-im-internet.de/englisch_agg/englisch_agg.html
- 45.Ministry of Justice Finland . Non-Discrimination Act (1325/2014) 2014. https://finlex.fi/fi/laki/kaannokset/2014/en20141325.pdf Date last accessed: 19 January 2024.
- 46.Government of the Netherlands . Algemene Wet Gelijke Behandeling [General Equal Treatment Act]. 2004. https://wetten.overheid.nl/BWBR0006502/2020-01-01 Date last accessed: 19 January 2024. Date last updated: 1 January 2020.
- 47.Government Equalities Office, Equality and Human Rights Commission . Equality Act 2010. 2010. www.legislation.gov.uk/ukpga/2010/15/contents Date last accessed: 19 January 2024. Date last updated: 17 January 2024.
- 48.Government Offices of Sweden . Diskrimineringslag (2008:567) [Discrimination Act, 2008:567]. 2008. www.do.se/choose-language/english/discrimination-act-2008567 Date last accessed: 19 January 2024. Date last updated: 2022.
- 49.Norwegian Ministry of Culture and Equality . Lov om likestilling og forbud mot diskriminering (likestillings- og diskrimineringsloven). [Act on Equality and Prohibition of Discrimination (Equality and Discrimination Act]. 2017. https://lovdata.no/static/lovtidend/ltavd1/2017/nl-20170616-051.pdf Date last accessed: 19 January 2024. Date last updated: 19 June 2017.
- 50.Conseil Constitutionnel. Constitution du 4 octobre 1958 (telle que modifiée jusqu'à la loi constitutionnelle n° 2008-724 du 23 juillet 2008 de modernisation des institutions de la Ve République). [Constitutional Law No. 2008-724 of July 23, 2008 on the modernization of the institutions of the Fifth Republic]. 2008. www.legifrance.gouv.fr/loda/id/JORFTEXT000019237256 Date last accessed: 19 January 2024. Date last updated: 19 January 2024.
- 51.Boletín Oficial del Estado . Ley 15/2022, de 12 de julio, integral para la igualdad de trato y la no discriminación. [Law 15/2022, of July 12, comprehensive for equal treatment and non-discrimination]. 2022. www.boe.es/eli/es/l/2022/07/12/15 Date last accessed: 19 January 2024. Date last updated: 13 July 2022.
- 52.United Nations . Declaration of the High-Level Meeting of the General Assembly on the Rule of Law at the National and International Levels. 30 November 2012. https://www.un.org/ruleoflaw/high-level-meeting-on-the-rule-of-law-2012/ Date last accessed: 26 April 2024.
- 53.United Nations . Equality and Non-discrimination. 2019. www.un.org/ruleoflaw/thematic-areas/human-rights/equality-and-non-discrimination/ Date last accessed: 18 August 2023.
- 54.Tricco AC, Lillie E, Zarin W, et al. PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation. Ann Intern Med 2018; 169: 467–473. doi: 10.7326/M18-0850 [DOI] [PubMed] [Google Scholar]
- 55.Drover H, Daynes E, Gardiner L, et al. Collection and Reporting of Equality Act 2010 Protected Characteristics within Pulmonary Rehabilitation Services and Research Data Collection in the United Kingdom: A Scoping Review Protocol. 2022. Available from: https://osf.io/c7vx2
- 56.British Thoracic Society . Quality Standards for Pulmonary Rehabilitation in Adults. London, British Thoracic Society, 2014. [Google Scholar]
- 57.Ouzzani M, Hammady H, Fedorowicz Z, et al. Rayyan – a web and mobile app for systematic reviews. Syst Rev 2016; 5: 210. doi: 10.1186/s13643-016-0384-4 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 58.Stonewall . List of LGBTQ+ Terms. 2023. www.stonewall.org.uk/list-lgbtq-terms Date last accessed: 26 April 2024.
- 59.Yohannes AM, Dryden S, Casaburi R, et al. Long-term benefits of pulmonary rehabilitation in patients with COPD: a 2-year follow-up study. Chest 2021; 159: 967–974. doi: 10.1016/j.chest.2020.10.032 [DOI] [PubMed] [Google Scholar]
- 60.Wynne SC, Patel S, Barker RE, et al. Anxiety and depression in bronchiectasis: response to pulmonary rehabilitation and minimal clinically important difference of the Hospital Anxiety and Depression Scale. Chron Respir Dis 2020; 17: 1479973120933292. doi: 10.1177/1479973120933292 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 61.Ward S, Orme M, Zatloukal J, et al. Adherence to walking exercise prescription during pulmonary rehabilitation in COPD with a commercial activity monitor: a feasibility trial. BMC Pulm Med 2021; 21: 30. doi: 10.1186/s12890-021-01406-9 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 62.Ricketts HC, Sharma V, Steffensen F, et al. A pragmatic randomised controlled trial of tailored pulmonary rehabilitation in participants with difficult-to-control asthma and elevated body mass index. BMC Pulm Med 2022; 22: 363. doi: 10.1186/s12890-022-02152-2 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 63.Pavitt MJ, Tanner RJ, Lewis A, et al. Oral nitrate supplementation to enhance pulmonary rehabilitation in COPD: ON-EPIC a multicentre, double-blind, placebo-controlled, randomised parallel group study. Thorax 2020; 75: 547–555. doi: 10.1136/thoraxjnl-2019-214278 [DOI] [PubMed] [Google Scholar]
- 64.Patel S, Palmer MD, Nolan CM, et al. Supervised pulmonary rehabilitation using minimal or specialist exercise equipment in COPD: a propensity-matched analysis. Thorax 2021; 76: 264–271. doi: 10.1136/thoraxjnl-2020-215281 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 65.Patel S, Cole AD, Nolan CM, et al. Pulmonary rehabilitation in bronchiectasis: a propensity-matched study. Eur Respir J 2019; 53: 1801264. doi: 10.1183/13993003.01264-2018 [DOI] [PubMed] [Google Scholar]
- 66.O'Neill B, O'Shea O, McDonough S, et al. Clinician-facilitated physical activity intervention versus pulmonary rehabilitation for improving physical activity in COPD: a feasibility study. COPD 2018; 15: 254–264. doi: 10.1080/15412555.2018.1486396 [DOI] [PubMed] [Google Scholar]
- 67.Nolan CM, Polgar O, Schofield SJ, et al. Pulmonary rehabilitation in idiopathic pulmonary fibrosis and COPD: a propensity-matched real-world study. Chest 2022; 161: 728–737. doi: 10.1016/j.chest.2021.10.021 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 68.Nolan CM, Maddocks M, Canavan JL, et al. Pedometer step count targets during pulmonary rehabilitation in chronic obstructive pulmonary disease: a randomized controlled trial. Am J Respir Crit Care Med 2017; 195: 1344–1352. doi: 10.1164/rccm.201607-1372OC [DOI] [PMC free article] [PubMed] [Google Scholar]
- 69.Nolan CM, Kaliaraju D, Jones SE, et al. Home versus outpatient pulmonary rehabilitation in COPD: a propensity-matched cohort study. Thorax 2019; 74: 996–998. doi: 10.1136/thoraxjnl-2018-212765 [DOI] [PubMed] [Google Scholar]
- 70.Majd S, Apps L, Chantrell S, et al. A feasibility study of a randomized controlled trial of asthma-tailored pulmonary rehabilitation compared with usual care in adults with severe asthma. J Allergy Clin Immunol Pract 2020; 8: 3418–3427. doi: 10.1016/j.jaip.2020.05.052 [DOI] [PubMed] [Google Scholar]
- 71.Maddocks M, Kon SSC, Canavan JL, et al. Physical frailty and pulmonary rehabilitation in COPD: a prospective cohort study. Thorax 2016; 71: 988–995. doi: 10.1136/thoraxjnl-2016-208460 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 72.Lewis A, Knight E, Bland M, et al. Feasibility of an online platform delivery of pulmonary rehabilitation for individuals with chronic respiratory disease. BMJ Open Respir Res 2021; 8: e000880. doi: 10.1136/bmjresp-2021-000880 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 73.Knox L, Dunning M, Davies CA, et al. Safety, feasibility, and effectiveness of virtual pulmonary rehabilitation in the real world. Int J Chron Obstruct Pulmon Dis 2019; 14: 775–780. doi: 10.2147/COPD.S193827 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 74.Jung T, Moorhouse N, Shi X, et al. A virtual reality-supported intervention for pulmonary rehabilitation of patients with chronic obstructive pulmonary disease: mixed methods study. J Med Internet Res 2020; 22: e14178. doi: 10.2196/14178 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 75.Jones SE, Green SA, Clark AL, et al. Pulmonary rehabilitation following hospitalisation for acute exacerbation of COPD: referrals, uptake and adherence. Thorax 2014; 69: 181–182. doi: 10.1136/thoraxjnl-2013-204227 [DOI] [PubMed] [Google Scholar]
- 76.Jones SE, Maddocks M, Kon SSC, et al. Sarcopenia in COPD: prevalence, clinical correlates and response to pulmonary rehabilitation. Thorax 2015; 70: 213–218. doi: 10.1136/thoraxjnl-2014-206440 [DOI] [PubMed] [Google Scholar]
- 77.Jenkins AR, Holden NS, Gibbons LP, et al. Clinical outcomes and inflammatory responses of the frequent exacerbator in pulmonary rehabilitation: a prospective cohort study. COPD 2020; 17: 253–260. doi: 10.1080/15412555.2020.1753669 [DOI] [PubMed] [Google Scholar]
- 78.Jenkins AR, Holden NS, Jones AW. Inflammatory responses to acute exercise during pulmonary rehabilitation in patients with COPD. Eur J Appl Physiol 2020; 120: 2301–2309. doi: 10.1007/s00421-020-04452-z [DOI] [PMC free article] [PubMed] [Google Scholar]
- 79.France G, Orme MW, Greening NJ, et al. Cognitive function following pulmonary rehabilitation and post-discharge recovery from exacerbation in people with COPD. Respir Med 2021; 176: 106249. doi: 10.1016/j.rmed.2020.106249 [DOI] [PubMed] [Google Scholar]
- 80.Chaplin E, Hewitt S, Apps L, et al. Interactive web-based pulmonary rehabilitation programme: a randomised controlled feasibility trial. BMJ Open 2017; 7: e013682. doi: 10.1136/bmjopen-2016-013682 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 81.Chaplin E, Gibb M, Sewell L, et al. Response of the COPD Assessment Tool in stable and postexacerbation pulmonary rehabilitation populations. J Cardiopulm Rehabil Prev 2015; 35: 214–218. doi: 10.1097/HCR.0000000000000090 [DOI] [PubMed] [Google Scholar]
- 82.Chaplin E, Barnes A, Newby C, et al. Comparison of the impact of conventional and web-based pulmonary rehabilitation on physical activity in patients with chronic obstructive pulmonary disease: exploratory feasibility study. JMIR Rehabil Assist Technol 2022; 9: e28875. doi: 10.2196/28875 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 83.Chalmers JD, Crichton ML, Brady G, et al. Pulmonary rehabilitation after exacerbation of bronchiectasis: a pilot randomized controlled trial. BMC Pulm Med 2019; 19: 85. doi: 10.1186/s12890-019-0856-0 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 84.Briggs-Price S, Daynes E, Chaplin E, et al. Exploring the prevalence and impact of hip and knee pain in pulmonary rehabilitation: a propensity-matched cohort study. Respir Res 2022; 23: 146. doi: 10.1186/s12931-022-02049-y [DOI] [PMC free article] [PubMed] [Google Scholar]
- 85.Boutou AK, Tanner RJ, Lord VM, et al. An evaluation of factors associated with completion and benefit from pulmonary rehabilitation in COPD. BMJ Open Respir Res 2014; 1: e000051. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 86.Bourne S, DeVos R, North M, et al. Online versus face-to-face pulmonary rehabilitation for patients with chronic obstructive pulmonary disease: randomised controlled trial. BMJ Open 2017; 7: e014580. doi: 10.1136/bmjopen-2016-014580 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 87.Barlow R, Jones B, Rogerson M, et al. An evaluation of service provision and novel strength assessment on patient outcomes in a UK-based pulmonary rehabilitation setting. COPD 2020; 17: 280–288. doi: 10.1080/15412555.2020.1764519 [DOI] [PubMed] [Google Scholar]
- 88.Andrews L, Barlow R, Easton I. Differences in patient outcomes between a 6, 7 and 8 week pulmonary rehabilitation programme: a service evaluation. Physiotherapy 2015; 101: 62–68. doi: 10.1016/j.physio.2014.04.002 [DOI] [PubMed] [Google Scholar]
- 89.Aldabayan YS, Ridsdale HA, Alrajeh AM, et al. Pulmonary rehabilitation, physical activity and aortic stiffness in COPD. Respir Res 2019; 20: 166. doi: 10.1186/s12931-019-1135-6 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 90.Cox M, O'Connor C, Biggs K, et al. The feasibility of early pulmonary rehabilitation and activity after COPD exacerbations: external pilot randomised controlled trial, qualitative case study and exploratory economic evaluation. Health Technol Assess 2018; 22: 1–204. doi: 10.3310/hta22110 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 91.Yohannes AM, Casaburi R, Dryden S, et al. The effectiveness of pulmonary rehabilitation on chronic obstructive pulmonary disease patients with concurrent presence of comorbid depression and anxiety. Respir Med 2022; 197: 106850. doi: 10.1016/j.rmed.2022.106850 [DOI] [PubMed] [Google Scholar]
- 92.Yohannes AM, Casaburi R, Dryden S, et al. Predictors of premature discontinuation and prevalence of dropouts from a pulmonary rehabilitation program in patients with chronic obstructive pulmonary disease. Respir Med 2022; 193: 106742. doi: 10.1016/j.rmed.2022.106742 [DOI] [PubMed] [Google Scholar]
- 93.McDonnell LM, Hogg L, McDonnell L. Pulmonary rehabilitation and sleep quality: a before and after controlled study of patients with chronic obstructive pulmonary disease. NPJ Prim Care Respir Med 2014; 24: 14028. doi: 10.1038/npjpcrm.2014.28 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 94.Armstrong M, Hume E, McNeillie L, et al. Behavioural modification interventions alongside pulmonary rehabilitation improve COPD patients’ experiences of physical activity. Respir Med 2021; 180: 106353. doi: 10.1016/j.rmed.2021.106353 [DOI] [PubMed] [Google Scholar]
- 95.Edwards GD, Polgar O, Patel S, et al. Mood disorder in idiopathic pulmonary fibrosis: Response to pulmonary rehabilitation. ERJ Open Res 2023; 9: 00585-2022. doi: 10.1183/23120541.00585-2022 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 96.Finnegan SL, Harrison OK, Booth S, et al. The effect of d-cycloserine on brain processing of breathlessness over pulmonary rehabilitation: an experimental medicine study. ERJ Open Res 2023; 9: 00479-2022. doi: 10.1183/23120541.00479-2022 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 97.Nikoletou D, Chis Ster I, Lech CY, et al. Comparison of high-intensity interval training versus moderate-intensity continuous training in pulmonary rehabilitation for interstitial lung disease: a randomised controlled pilot feasibility trial. BMJ Open 2023; 13: e066609. doi: 10.1136/bmjopen-2022-066609 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 98.Bradley G, Rooney L, Whitehead PJ. Service user perspectives on engagement in an occupational therapy-led pulmonary rehabilitation programme: a qualitative interview study. Br J Occup Ther 2022; 85: 984–992. doi: 10.1177/03080226221103155 [DOI] [Google Scholar]
- 99.Patel S, Jones SE, Walsh JA, et al. The six-minute step test as an exercise outcome in chronic obstructive pulmonary disease. Ann Am Thorac Soc 2023; 20: 476–479. doi: 10.1513/AnnalsATS.202206-516RL [DOI] [PMC free article] [PubMed] [Google Scholar]
- 100.Page MJ, McKenzie JE, , Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 2021; 372: n71. doi: 10.1136/bmj.n71 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 101.Singh S, Latchem S, Andrews R, et al. National Asthma and Chronic Obstructive Pulmonary Disease Audit Programme (NACAP). Pulmonary Rehabilitation Clinical Audit 2019. Clinical Audit of Pulmonary Rehabilitation Services in England, Scotland and Wales. Patients Assessed between 1 June and 30 November. Clinical audit: Data Anaylsis and Methodology Report. London, Royal College of Physicians, 2020. [Google Scholar]
- 102.Singh S, Legg M, Garnavos N, et al. National Asthma and Chronic Obstructive Pulmonary Disease Audit Programme (NACAP). Pulmonary Rehabilitation Clinical Audit 2019. Clinical Audit of Pulmonary Rehabilitation Services in England, Scotland and Wales. Patients Assessed Between 1 March and 31 May and Discharged by 31 August 2019. Clinical Audit Interim Report. London, Royal College of Physicians, 2020. [Google Scholar]
- 103.Steiner M, Holzhauer-Barrie J, Lowe D, et al. Pulmonary Rehabilitation: Steps to Breathe Better. National Chronic Obstructive Pulmonary Disease (COPD) Audit Programme: Clinical Audit of Pulmonary Rehabilitation Services in England and Wales 2015. National Clinical Audit Report. London, Royal College of Physicians, 2016. [Google Scholar]
- 104.Hosseinpoor AR, Bergen N. National Health Inequality Monitoring: A Step-by-step Manual. Geneva, World Health Organization, 2017. [Google Scholar]
- 105.Public Health England . Local Action on Health Inequalities: Understanding and Reducing Ethnic Inequalities in Health. London, Public Health England, 2018. [Google Scholar]
- 106.Office for National Statistics . Equalities Data Audit, Final Report. 2018. www.ons.gov.uk/methodology/methodologicalpublications/generalmethodology/onsworkingpaperseries/equalitiesdataauditfinalreport Date last accessed: 18 January 24.
- 107.Khunti K, Bellary S, Karamat MA, et al. Representation of people of South Asian origin in cardiovascular outcome trials of glucose-lowering therapies in type 2 diabetes. Diabet Med 2017; 34: 64–68. doi: 10.1111/dme.13103 [DOI] [PubMed] [Google Scholar]
- 108.Zhang J, Van Spall HGC, Wang Y, et al. Twenty-year trends in racial and ethnic enrollment in large diabetes randomized controlled trials. BMC Med 2022; 20: 294. doi: 10.1186/s12916-022-02501-2 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 109.Hosseinpoor AR, Bergen N, Kirkby K, et al. Strengthening and expanding health inequality monitoring for the advancement of health equity: a review of WHO resources and contributions. Int J Equity Health 2023; 22: 49. doi: 10.1186/s12939-022-01811-4 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 110.Baker KE, Streed CG, Durso LE. Ensuring that LGBTQI+ people count – collecting data on sexual orientation, gender identity, and intersex status. N Engl J Med 2021; 384: 1184–1186. doi: 10.1056/NEJMp2032447 [DOI] [PubMed] [Google Scholar]
- 111.Ly L, Pascoe A, Philip J, et al. Social determinants of advanced chronic respiratory interventions: a scoping review. Eur Respir Rev 2023; 32: 230068. doi: 10.1183/16000617.0068-2023 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 112.World Health Organization . A Conceptual Framework for Action on the Social Determinants of Health. Geneva, World Health Organization, 2010. [Google Scholar]
- 113.Pasterny L. Do Ask, Do Tell: Capturing Data on Sexual Orientation and Gender Identity Globally. 2019. www.stonewall.org.uk/sites/default/files/do_ask_do_tell_guide_2016.pdf
- 114.Office for National Statistics . Gender Identity, England and Wales: Census 2021. www.ons.gov.uk/peoplepopulationandcommunity/culturalidentity/genderidentity/bulletins/genderidentityenglandandwales/census2021 Date last accessed: 16 February 2024. Date last updated: 6 January 2023.
- 115.Office of the United Nations High Commissioner for Human Rights . Intersex People: OHCHR and the Human Rights of LGBTI People. 2023. www.ohchr.org/en/sexual-orientation-and-gender-identity/intersex-people#:∼:text=Experts%20estimate%20that%20up%20to,as%20heterosexual%20(sexual%20orientation Date last accessed: 16 February 2024.
- 116.Oakley PA. Sex, Gender and Society. Farnham, Ashgate, 2015. [Google Scholar]
- 117.World Health Organization . Gender and Health. www.who.int/news-room/questions-and-answers/item/gender-and-health Date last accessed 16 August 2023. Date last updated: 24 May 2021.
- 118.Coen S, Banister E. What a Difference Sex and Gender Make: a Gender, Sex and Health Research Casebook. Ottawa, CIHR Institute of Gender and Health, 2012. [Google Scholar]
- 119.Madsen TE, Bourjeily G, Hasnain M, et al. Article commentary: sex- and gender-based medicine: the need for precise terminology. Gend Genome 2017; 1: 122–128. doi: 10.1089/gg.2017.0005 [DOI] [Google Scholar]
- 120.Peters SAE, Norton R. Sex and gender reporting in global health: new editorial policies. BMJ Glob Health 2018; 3: e001038. doi: 10.1136/bmjgh-2018-001038 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 121.Gogovor A, Zomahoun HTV, Ekanmian G, et al. Sex and gender considerations in reporting guidelines for health research: a systematic review. Biol Sex Differ 2021; 12: 62. doi: 10.1186/s13293-021-00404-0 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 122.Office for National Statistics . Ethnic Group, National Identity and Religion. 2021. www.ons.gov.uk/methodology/classificationsandstandards/measuringequality/ethnicgroupnationalidentityandreligion
- 123.Lee C. “Race” and “ethnicity” in biomedical research: how do scientists construct and explain differences in health? Soc Sci Med 2009; 68: 1183–1190. doi: 10.1016/j.socscimed.2008.12.036 [DOI] [PubMed] [Google Scholar]
- 124.Darko N. Engaging Black and Minority Ethnic Groups in Health Research: ‘Hard to Reach’? Demystifying the Misconceptions. Bristol, Policy Press, 2021. [Google Scholar]
- 125.Balestra C, Fleischer L. Diversity Statistics in the OECD. How do OECD Countries Collect Data on Ethnic, Racial and Indigenous Identity? Organisation for Economic Co-operation and Development, 2018. 10.1787/89bae654-en [DOI] [Google Scholar]
- 126.Tahhan AS, Vaduganathan M, Greene SJ, et al. Enrollment of older patients, women, and racial/ethnic minority groups in contemporary acute coronary syndrome clinical trials: a systematic review. JAMA Cardiol 2020; 5: 714–722. doi: 10.1001/jamacardio.2020.0359 [DOI] [PubMed] [Google Scholar]
- 127.Bowe T, Salabati M, Soares RR, et al. Racial, ethnic, and gender disparities in diabetic macular edema clinical trials. Ophthalmol Retina 2022; 6: 531–533. doi: 10.1016/j.oret.2022.01.018 [DOI] [PubMed] [Google Scholar]
- 128.Murali M, Gumber L, Jethwa H, et al. Ethnic minority representation in UK COVID-19 trials: systematic review and meta-analysis. BMC Med 2023; 21: 111. doi: 10.1186/s12916-023-02809-7 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 129.Pan D, Sze S, Minhas JS, et al. The impact of ethnicity on clinical outcomes in COVID-19: a systematic review. eClinicalMedicine 2020; 23: 100404. doi: 10.1016/j.eclinm.2020.100404 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 130.Ekezie W, Czyznikowska BM, Rohit S, et al. The views of ethnic minority and vulnerable communities towards participation in COVID-19 vaccine trials. J Public Health 2021; 43: e258–ee60. doi: 10.1093/pubmed/fdaa196 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 131.Cahill S, Singal R, Grasso C, et al. Do ask, do tell: high levels of acceptability by patients of routine collection of sexual orientation and gender identity data in four diverse American community health centers. PLoS One 2014; 9: e107104. doi: 10.1371/journal.pone.0107104 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 132.Haider AH, Schneider EB, Kodadek LM, et al. Emergency department query for patient-centered approaches to sexual orientation and gender identity: the EQUALITY study. JAMA Intern Med 2017; 177: 819–828. doi: 10.1001/jamainternmed.2017.0906 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 133.Baker DW, Cameron KA, Feinglass J, et al. Patients’ attitudes toward health care providers collecting information about their race and ethnicity. J Gen Intern Med 2005; 20: 895–900. doi: 10.1111/j.1525-1497.2005.0195.x [DOI] [PMC free article] [PubMed] [Google Scholar]
- 134.Clayton JA, Tannenbaum C. Reporting sex, gender, or both in clinical research? JAMA 2016; 316: 1863–1864. doi: 10.1001/jama.2016.16405 [DOI] [PubMed] [Google Scholar]
- 135.Heidari S, Babor TF, De Castro P, et al. Sex and Gender Equity in Research: rationale for the SAGER guidelines and recommended use. Res Integr Peer Rev 2016; 1: 2. doi: 10.1186/s41073-016-0007-6 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 136.Khunti K, Routen A, Banerjee A, et al. The need for improved collection and coding of ethnicity in health research. J Public Health 2020; 43: e270–e272. doi: 10.1093/pubmed/fdaa198 [DOI] [PubMed] [Google Scholar]
- 137.Flanagin A, Frey T, Christiansen SL, et al. Updated guidance on the reporting of race and ethnicity in medical and science journals. JAMA 2021; 326: 621–627. doi: 10.1001/jama.2021.13304 [DOI] [PubMed] [Google Scholar]
- 138.International Committee of Medical Journal Editors . Preparing a Manuscript for Submission to a Medical Journal. www.icmje.org/recommendations/browse/manuscript-preparation/preparing-for-submission.html Date last accessed: 16 August 2023. Date last updated: May 2023.
- 139.Decision no. 2007-557 DC of 15 November 2007. Act Relating to the Control of Immigration, Integration and Asylum. 2007-557 DC (2007). Available from: www.conseil-constitutionnel.fr/en/decision/2007/2007557DC.htm
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Please note: supplementary material is not edited by the Editorial Office, and is uploaded as it has been supplied by the author.
Supplementary material ERR-0236-2023.SUPPLEMENT (813.4KB, pdf)